tiprankstipranks
Trending News
More News >
Frontage Holdings Corp. (HK:1521)
:1521
Hong Kong Market

Compare Frontage Holdings Corp. (1521) vs. Competitors

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Frontage Holdings Corp.
HK$1.03
HK$2.16B
72.11
-37.65%
Genscript Biotech
HK$14.33
HK$27.95B
20.32%
2 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$21.38
HK$36.44B
-20.84
94.36%
0 Buy
1 Hold
0 Sell
Hold
Simcere Pharmaceutical Group Limited
HK$11.69
HK$30.34B
30.28
70.66%
2 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Henlius Biotech, Inc. Class H
HK$58.60
HK$31.14B
34.99
241.89%
Shandong Boan Biotechnology Company., Limited. Class H
HK$8.33
HK$5.18B
134.79
-4.25%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:1521
Frontage Holdings Corp.
1.06
-0.60
-36.14%
HK:1548
Genscript Biotech
12.85
2.33
22.15%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
21.38
10.78
101.70%
HK:2096
Simcere Pharmaceutical Group Limited
11.69
4.88
71.66%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
57.30
40.32
237.46%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
8.33
-0.37
-4.25%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts